Pemetrexed in Recurrent or Progressive Central Nervous System Lymphoma: A Phase I Multicenter Clinical Trial

LESSONS LEARNED: The findings from this study using monotherapy with pemetrexed in a pretreated patient population are, overall, encouraging. Unlike high‐dose methotrexate, which requires several days of inpatient hospitalization, pemetrexed is relatively easy to administer in the outpatient setting...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Dietrich, Jorg, Versmee, Laura, Drappatz, Jan, Eichler, April F., Nayak, Lakshmi, Norden, Andrew, Wong, Eric, Pisapia, Michelle R., Jones, SooAe S., Gordon, Amanda B., Chabner, Bruce A., Hochberg, Fred, Batchelor, Tracy T.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7485351/
https://ncbi.nlm.nih.gov/pubmed/32520407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0489
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados